The global neurovascular intervention market is poised to reach nearly US$ 4 Billion by 2021. The market growth is attributed to factors such as an increased adoption of neurovascular devices, ageing population, rising prevalence of cerebrovascular diseases, technological advancements and deal making activity globally. However, the factors such as regulatory standards and compliance, unmet needs and a dearth of skilled neurosurgeons are restraining the growth of neurovascular interventional market.
By Device Category Neurovascular Intervention Market Analysis –
In terms of device category, Coil represents the largest market for neurovascular intervention controlling XX% share in 2015. Coil segment is facing increased competition from the emerging Carotid Stent, Micro wire/Catheter and Clot Removal device. The increasing adoption of emerging technologies such as flow diverters is likely to take market share away from the stent-assisted and balloon-assisted coiling markets. The coil assist balloon captured smallest share of the neurovascular intervention market.
Check the DISCOUNT on this report @ http://orbisresearch.com/contacts/discount/175219 .
By Disease Segment Neurovascular Intervention Market Analysis – Aneurysm disease segment accounts for the largest share of the global neurovascular intervention market. Arteriovenous Malformation (AVM) captures the second largest share of the total neurovascular intervention market, being followed by ischemic stroke. Intracranial atherosclerotic disease (ICAD) captured least share of the neurovascular intervention market.
Neurovascular Intervention Market Country Analysis – United States is at the forefront of neurovascular intervention market, and is likely to remain the leader throughout the forecasting period. Japan is the second leading market for neurovascular intervention being followed by China. In European region, Germany and France are leading the way in neurovascular intervention market and are competing closely with each other to grab maximum share of the pie. In Latin American countries, Brazil accounted for XX% share of the global neurovascular intervention market in 2015. Italy, Spain, United Kingdom and India represents a major market growth area.
Neurovascular Intervention Market Company Analysis – Medtronic and Stryker dominated the global neurovascular intervention market. They together accounted for over 45% share of the global neurovascular intervention market in 2015. DePuy Synthes captured third highest share of the total neurovascular intervention market in 2015, while Terumo Corporation and Penumbra Inc. are competing closely with each other to capture maximum share of the pie.
Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/175219 .
iGATE RESEARCH report titled “Neurovascular Intervention Market (by Device Category, Disease Segment, Country Wise and Company) and Forecast to 2021 – Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth global neurovascular intervention market. This report covers various aspects of the neurovascular intervention market including Device Category, Disease Segment, Country Wise Market, Company Sales and Product Portfolio Analysis, Competitive Landscape of Major Neurovascular Companies, and the Growth Drivers and Challenges influencing global neurovascular intervention market.
Major List of Table
Table 3-1: By Device Category – Global Neurovascular Intervention Market Share (Percent), 2009 – 2015
Table 3-2: By Device Category – Forecast for Global Neurovascular Intervention Market Share (Percent), 2016 – 2021
Table 3-3: By Country – Neurovascular Intervention Market Share (Percent), 2013 – 2015
Table 3-4: By Country – Forecast for Neurovascular Intervention Market Share (Percent), 2016 – 2021
Table 3-5: By Company – Global Neurovascular Intervention Market Share (Percent), 2013 – 2015
Table 3-6: By Company – Forecast for Global Neurovascular Intervention Market Share (Percent), 2016 – 2021
Table 4-1: Flow Diverter Devices Approval Status
Table 8-1: Neurovascular Intervention – Merger and Acquisitions, 2006 – 2016
Table 9-1: Neurovascular Intervention Market – Approved Products
Table 10-1: Competitive Landscape of Major Neurovascular Companies
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: firstname.lastname@example.org